HYDROXYUREA AND ETOPOSIDE - INVITRO SYNERGY AND PHASE-I CLINICAL-TRIAL

被引：12

作者：

RATAIN, MJ

SCHILSKY, RL

WOJACK, BR

SIMON, T

SENEKJIAN, EK

VOGELZANG, NJ

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,HEMATOL ONCOL JOINT SECT,CHICAGO,IL 60637

[2] UNIV CHICAGO,PRITZKER SCH MED,DEPT OBSTET & GYNECOL,CHICAGO,IL 60637

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1988年 / 80卷 / 17期

关键词：

D O I：

10.1093/jnci/80.17.1412

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1412 / 1416

页数：5

共 15 条

[1]

ACKLAND SP, 1988, CANCER RES, V48, P4244

[2] EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) ON NUCLEAR TOPOISOMERASE-II ACTIVITY AND ON THE DNA CLEAVAGE AND CYTO-TOXICITY PRODUCED BY 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE (META-AMSA) AND ETOPOSIDE IN META-AMSA-SENSITIVE AND META-AMSA-RESISTANT HUMAN-LEUKEMIA CELLSD [J].

BAKIC, M ;

CHAN, D ;

ANDERSSON, BS ;

BERAN, M ;

SILBERMAN, L ;

ESTEY, E ;

RICKETTS, L ;

ZWELLING, LA .

BIOCHEMICAL PHARMACOLOGY, 1987, 36 (23) :4067-4077

[3]

BELT RJ, 1980, CANCER, V46, P455, DOI 10.1002/1097-0142(19800801)46:3<455::AID-CNCR2820460306>3.0.CO

[4]

2-N

[5]

BENNETT CL, 1987, CANCER RES, V47, P1952

[6] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].

CHOU, TC ;

TALALAY, P .

ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55

[7]

CHU MY, 1968, BIOCHEM PHARMACOL, V17, P753

[8]

GRECO WR, 1987, P AM ASSOC CANC RES, V28, P426

[9]

Loewe S., 1928, ERG PHYSIOL BIOL CH, V27, P47, DOI DOI 10.1007/BF02322290

[10]

LUDWIG R, 1984, CANCER CHEMOTH PHARM, V12, P142

← 1 2 →